Average Co-Inventor Count = 2.72
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Ptc Therapeutics, Inc. (17 from 184 patents)
2. Gilead Calistoga LLC (2 from 16 patents)
3. Pct Therapeutics, Inc. (0 patent)
19 patents:
1. 11497736 - Compositions for an orally active 1,2,4-oxadiazole for the treatment of disease
2. 10849885 - Methods for dosing an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy
3. 10675272 - Compositions for an orally active 1,2,4-oxadiazole for the treatment of disease
4. 10285980 - Compositions for an orally active 1,2,4-oxadiazole for the treatment of disease
5. 10172836 - Methods for dosing an orally active 1,2,4-oxadiazole for nonsense mutation supression therapy
6. 10154998 - Therapies for hematologic malignancies
7. 10034863 - Compositions for an orally active 1,2,4-oxadiazole for the treatment of disease
8. 9877952 - Methods for dosing an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy
9. 9737513 - Methods for dosing an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy
10. 9522137 - Methods for dosing an orally active 1,2,4-Oxadiazole for nonsense mutation suppression therapy
11. 9492449 - Therapies for hematologic malignancies
12. 9474743 - Compositions for an orally active 1,2,4-oxadiazole for the treatment of disease
13. 9351964 - Methods for treating cancer and non-neoplastic conditions
14. 9289398 - Methods for the production of functional protein from DNA having a nonsense mutation and the treatment of disorders associated therewith
15. 9226919 - Methods for dosing an orally active 1,2,4-oxadiazole